Obesity and renal cancer

References

• Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008; 34:193 - 205; http://dx.doi.org/10.1016/j.ctrv.2007.12.001; PMID: 18313224
   PubMed Web of Science ®Google Scholar
• Dhote R, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol Clin North Am 2004; 31:237 - 47; http://dx.doi.org/10.1016/j.ucl.2004.01.004; PMID: 15123404
   PubMed Web of Science ®Google Scholar
• Duan XF, Tang P, Li Q, Yu ZT. Obesity, adipokines and hepatocellular carcinoma. Int J Cancer 2013; 133:1776 - 83; http://dx.doi.org/10.1002/ijc.28105; PMID: 23404222
   PubMed Web of Science ®Google Scholar
• McGuire BB, Fitzpatrick JM. BMI and the risk of renal cell carcinoma. Curr Opin Urol 2011; 21:356 - 61; http://dx.doi.org/10.1097/MOU.0b013e32834962d5; PMID: 21730854
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371:569 - 78; http://dx.doi.org/10.1016/S0140-6736(08)60269-X; PMID: 18280327
   PubMed Web of Science ®Google Scholar
• Dal Maso L, Zucchetto A, Tavani A, Montella M, Ramazzotti V, Talamini R, Canzonieri V, Garbeglio A, Negri E, Tonini A, et al. Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol 2007; 166:582 - 91; http://dx.doi.org/10.1093/aje/kwm108; PMID: 17591592
   PubMed Web of Science ®Google Scholar
• Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int 2010; 105:16 - 20; http://dx.doi.org/10.1111/j.1464-410X.2009.08706.x; PMID: 19583732
   PubMed Web of Science ®Google Scholar
• da Costa WH, Moniz RR, da Cunha IW, Fonseca FP, Guimaraes GC, de Cássio Zequi S. Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma. BJU Int 2012; 109:544 - 8; http://dx.doi.org/10.1111/j.1464-410X.2011.10366.x; PMID: 21711437
   PubMed Web of Science ®Google Scholar
• Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013; 132:625 - 34; http://dx.doi.org/10.1002/ijc.27639; PMID: 22610826
   PubMed Web of Science ®Google Scholar
• Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scand J Urol Nephrol 2012; 46:348 - 57; http://dx.doi.org/10.3109/00365599.2012.678382; PMID: 22530756
   PubMed Web of Science ®Google Scholar
• Imagawa K, Numata Y, Katsuura G, Sakaguchi I, Morita A, Kikuoka S, Matumoto Y, Tsuji T, Tamaki M, Sasakura K, et al. Structure-function studies of human leptin. J Biol Chem 1998; 273:35245 - 9; http://dx.doi.org/10.1074/jbc.273.52.35245; PMID: 9857064
   PubMed Web of Science ®Google Scholar
• Basak S, Duttaroy AK. Leptin induces tube formation in first-trimester extravillous trophoblast cells. Eur J Obstet Gynecol Reprod Biol 2012; 164:24 - 9; http://dx.doi.org/10.1016/j.ejogrb.2012.05.033; PMID: 22717511
   PubMed Web of Science ®Google Scholar
• Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol 2013; PMID: 23562747
   PubMed Web of Science ®Google Scholar
• Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol 2014; 382:570 - 82; http://dx.doi.org/10.1016/j.mce.2013.03.025; PMID: 23562747
   PubMed Web of Science ®Google Scholar
• Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP, Maihle NJ. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 2003; 77:205 - 15; http://dx.doi.org/10.1023/A:1021891825399; PMID: 12602920
   PubMed Web of Science ®Google Scholar
• Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP, Maihle NJ. Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) 2004; 229:182 - 93; PMID: 14734797
   PubMed Web of Science ®Google Scholar
• Perera CN, Chin HG, Duru N, Camarillo IG. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol 2008; 199:221 - 33; http://dx.doi.org/10.1677/JOE-08-0215; PMID: 18715880
   PubMed Web of Science ®Google Scholar
• Eto I. Expression of p27Kip1, a cell cycle repressor protein, is inversely associated with potential carcinogenic risk in the genetic rodent models of obesity and long-lived Ames dwarf mice. Metabolism 2013; 62:873 - 87; http://dx.doi.org/10.1016/j.metabol.2013.01.001; PMID: 23357529
   PubMed Web of Science ®Google Scholar
• Caldefie-Chézet F, Dubois V, Delort L, Rossary A, Vasson MP. [Leptin: Involvement in the pathophysiology of breast cancer]. Ann Endocrinol (Paris) 2013; 74:90 - 101; PMID: 23566612
   PubMed Web of Science ®Google Scholar
• Ptak A, Kolaczkowska E, Gregoraszczuk EL. Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine 2013; 43:394 - 403; http://dx.doi.org/10.1007/s12020-012-9788-7; PMID: 22968658
   PubMed Web of Science ®Google Scholar
• Liao LM, Schwartz K, Pollak M, Graubard BI, Li Z, Ruterbusch J, Rothman N, Davis F, Wacholder S, Colt J, et al. Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 2013; 21:1478 - 85; http://dx.doi.org/10.1002/oby.20138; PMID: 23666639
   PubMed Web of Science ®Google Scholar
• Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M. Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol 2006; 176:1636 - 41; http://dx.doi.org/10.1016/j.juro.2006.06.040; PMID: 16952706
   PubMed Web of Science ®Google Scholar
• Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M. Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 2006; 176:1631 - 5; http://dx.doi.org/10.1016/j.juro.2006.06.039; PMID: 16952705
   PubMed Web of Science ®Google Scholar
• Li L, Gao Y, Zhang LL, He DL. Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biol Ther 2008; 7:1787 - 92; http://dx.doi.org/10.4161/cbt.7.11.6837; PMID: 18787400
   PubMed Web of Science ®Google Scholar
• Mao X, Hong JY, Dong LQ. The adiponectin signaling pathway as a novel pharmacological target. Mini Rev Med Chem 2006; 6:1331 - 40; http://dx.doi.org/10.2174/138955706778992978; PMID: 17168809
   PubMed Web of Science ®Google Scholar
• Scheid MP, Sweeney G. The role of adiponectin signaling in metabolic syndrome and cancer. Rev Endocr Metab Disord 2013; Forthcoming http://dx.doi.org/10.1007/s11154-013-9265-5; PMID: 24019064
   PubMed Web of Science ®Google Scholar
• Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94:1221 - 5; http://dx.doi.org/10.1038/sj.bjc.6603051; PMID: 16570048
   PubMed Web of Science ®Google Scholar
• Kim KY, Kim JK, Han SH, Lim JS, Kim KI, Cho DH, Lee MS, Lee JH, Yoon DY, Yoon SR, et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 2006; 176:5958 - 64; PMID: 16670304
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005; 280:18341 - 7; http://dx.doi.org/10.1074/jbc.M501149200; PMID: 15734737
   PubMed Web of Science ®Google Scholar
• Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, et al. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res 2010; 16:967 - 77; http://dx.doi.org/10.1158/1078-0432.CCR-09-1487; PMID: 20103676
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96:1723 - 32; PMID: 10961870
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8:731 - 7; http://dx.doi.org/10.1038/nm724; PMID: 12068289
   PubMed Web of Science ®Google Scholar
• Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol 2008; 180:1137 - 40; http://dx.doi.org/10.1016/j.juro.2008.04.135; PMID: 18639282
   PubMed Web of Science ®Google Scholar
• Pinthus JH, Kleinmann N, Tisdale B, Chatterjee S, Lu JP, Gillis A, Hamlet T, Singh G, Farrokhyar F, Kapoor A. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 2008; 54:866 - 73; http://dx.doi.org/10.1016/j.eururo.2008.02.044; PMID: 18343565
   PubMed Web of Science ®Google Scholar
• Kleinmann N, Duivenvoorden WC, Hopmans SN, Beatty LK, Qiao S, Gallino D, Lhotak S, Daya D, Paschos A, Austin RC, et al. Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression. Clin Exp Metastasis 2013; Forthcoming http://dx.doi.org/10.1007/s10585-013-9618-1; PMID: 24096711
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010; 20:65 - 71; http://dx.doi.org/10.1016/j.gde.2009.11.004; PMID: 20036794
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Meijer K, de Vries M, Al-Lahham S, Bruinenberg M, Weening D, Dijkstra M, Kloosterhuis N, van der Leij RJ, van der Want H, Kroesen BJ, et al. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One 2011; 6:e17154; http://dx.doi.org/10.1371/journal.pone.0017154; PMID: 21448265
   PubMed Web of Science ®Google Scholar
• Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 2011; 1229:45 - 52; http://dx.doi.org/10.1111/j.1749-6632.2011.06096.x; PMID: 21793838
   PubMed Web of Science ®Google Scholar
• Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010; 184:873 - 8; http://dx.doi.org/10.1016/j.juro.2010.05.028; PMID: 20643463
   PubMed Web of Science ®Google Scholar
• Fitzgerald JP, Nayak B, Shanmugasundaram K, Friedrichs W, Sudarshan S, Eid AA, DeNapoli T, Parekh DJ, Gorin Y, Block K. Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production. PLoS One 2012; 7:e30712; http://dx.doi.org/10.1371/journal.pone.0030712; PMID: 22303451
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721 - 32; http://dx.doi.org/10.1038/nrc1187; PMID: 13130303
   PubMed Web of Science ®Google Scholar
• Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Adipose tissue immunity and cancer. Front Physiol 2013; 4:275; http://dx.doi.org/10.3389/fphys.2013.00275; PMID: 24106481
   PubMed Web of Science ®Google Scholar
• Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54:2277 - 86; http://dx.doi.org/10.2337/diabetes.54.8.2277; PMID: 16046292
   PubMed Web of Science ®Google Scholar
• Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005; 209 - 31; PMID: 15617481
   PubMedGoogle Scholar
• Gómez-Ambrosi J, Catalán V, Rodríguez A, Ramírez B, Silva C, Gil MJ, Salvador J, Frühbeck G. Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem 2010; 21:774 - 80; http://dx.doi.org/10.1016/j.jnutbio.2009.05.004; PMID: 19615882
   PubMed Web of Science ®Google Scholar
• George DJ, Kaelin WG Jr.. The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer. N Engl J Med 2003; 349:419 - 21; http://dx.doi.org/10.1056/NEJMp030061; PMID: 12890838
   PubMed Web of Science ®Google Scholar
• Ladoire S, Bonnetain F, Gauthier M, Zanetta S, Petit JM, Guiu S, Kermarrec I, Mourey E, Michel F, Krause D, et al. Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 2011; 16:71 - 81; http://dx.doi.org/10.1634/theoncologist.2010-0227; PMID: 21212435
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 2012; 7:e30563; http://dx.doi.org/10.1371/journal.pone.0030563; PMID: 22363446
   PubMed Web of Science ®Google Scholar
• Zhang Y, Daquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W, Kolonin MG. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 2009; 69:5259 - 66; http://dx.doi.org/10.1158/0008-5472.CAN-08-3444; PMID: 19491274
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bellows CF, Kolonin MG. Adipose tissue-derived progenitor cells and cancer. World J Stem Cells 2010; 2:103 - 13; http://dx.doi.org/10.4252/wjsc.v2.i5.103; PMID: 21607127
   PubMedGoogle Scholar
• Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell 2008; 135:240 - 9; http://dx.doi.org/10.1016/j.cell.2008.09.036; PMID: 18835024
   PubMed Web of Science ®Google Scholar
• Kushiro K, Chu RA, Verma A, Núñez NP. Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition. Cancer Microenviron 2012; 5:73 - 82; http://dx.doi.org/10.1007/s12307-011-0087-2; PMID: 21892698
   PubMedGoogle Scholar
• Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res 2012; 10:1109 - 19; http://dx.doi.org/10.1158/1541-7786.MCR-12-0160; PMID: 22707636
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17:1498 - 503; http://dx.doi.org/10.1038/nm.2492; PMID: 22037646
   PubMed Web of Science ®Google Scholar
• Dovio A, Caramello V, Masera RG, Sartori ML, Saba L, Tinivella M, Prolo P, Termine A, Avagnina P, Angeli A. Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition. Int J Obes Relat Metab Disord 2004; 28:894 - 901; http://dx.doi.org/10.1038/sj.ijo.0802639; PMID: 15208649
   PubMed Web of Science ®Google Scholar
• Nave H, Mueller G, Siegmund B, Jacobs R, Stroh T, Schueler U, Hopfe M, Behrendt P, Buchenauer T, Pabst R, et al. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008; 149:3370 - 8; http://dx.doi.org/10.1210/en.2007-1516; PMID: 18356278
   PubMed Web of Science ®Google Scholar
• Lautenbach A, Budde A, Wrann CD, Teichmann B, Vieten G, Karl T, Nave H. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer 2009; 61:484 - 91; http://dx.doi.org/10.1080/01635580802610115; PMID: 19838920
   PubMed Web of Science ®Google Scholar
• Wrann CD, Laue T, Hübner L, Kuhlmann S, Jacobs R, Goudeva L, Nave H. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab 2012; 302:E108 - 16; http://dx.doi.org/10.1152/ajpendo.00057.2011; PMID: 21952038
   PubMed Web of Science ®Google Scholar
• Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68:437 - 46; PMID: 11037963
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002; 72:330 - 8; PMID: 12149424
   PubMed Web of Science ®Google Scholar
• Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005; 174:6820 - 8; PMID: 15905523
   PubMed Web of Science ®Google Scholar
• Fernández-Riejos P, Goberna R, Sánchez-Margalet V. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. Clin Exp Immunol 2008; 151:505 - 18; http://dx.doi.org/10.1111/j.1365-2249.2007.03563.x; PMID: 18234059
   PubMed Web of Science ®Google Scholar
• Fujita Y, Murakami M, Ogawa Y, Masuzaki H, Tanaka M, Ozaki S, Nakao K, Mimori T. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002; 128:21 - 6; http://dx.doi.org/10.1046/j.1365-2249.2002.01797.x; PMID: 11982586
   PubMed Web of Science ®Google Scholar
• De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26:241 - 55; http://dx.doi.org/10.1016/j.immuni.2007.01.011; PMID: 17307705
   PubMed Web of Science ®Google Scholar
• Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M, Crozet L, Ouakrim H, Goc J, Cazes A, et al. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res 2013; 19:4079 - 91; http://dx.doi.org/10.1158/1078-0432.CCR-12-3847; PMID: 23785047
   PubMed Web of Science ®Google Scholar
• Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013; 73:128 - 38; http://dx.doi.org/10.1158/0008-5472.CAN-12-2606; PMID: 23135914
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323:630 - 5; http://dx.doi.org/10.1016/j.bbrc.2004.08.145; PMID: 15369797
   PubMed Web of Science ®Google Scholar
• Tsang JY, Li D, Ho D, Peng J, Xu A, Lamb J, Chen Y, Tam PK. Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int Immunopharmacol 2011; 11:604 - 9; http://dx.doi.org/10.1016/j.intimp.2010.11.009; PMID: 21094289
   PubMed Web of Science ®Google Scholar
• Jung MY, Kim HS, Hong HJ, Youn BS, Kim TS. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. J Immunol 2012; 188:2592 - 601; http://dx.doi.org/10.4049/jimmunol.1102588; PMID: 22345647
   PubMed Web of Science ®Google Scholar
• Oudard S, Rixe O, Beuselinck B, Linassier C, Banu E, Machiels JP, Baudard M, Ringeisen F, Velu T, Lefrere-Belda MA, et al. A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother 2011; 60:261 - 71; http://dx.doi.org/10.1007/s00262-010-0935-9; PMID: 21069322
   PubMed Web of Science ®Google Scholar
• Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18:1254 - 61; http://dx.doi.org/10.1038/nm.2883; PMID: 22842478
   PubMed Web of Science ®Google Scholar
• Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res 2003; 63:7475 - 82; PMID: 14612548
   PubMed Web of Science ®Google Scholar
• Guerra N, Guillard M, Angevin E, Echchakir H, Escudier B, Moretta A, Chouaib S, Caignard A. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Blood 2000; 95:2883 - 9; PMID: 10779435
   PubMed Web of Science ®Google Scholar
• Eckl J, Buchner A, Prinz PU, Riesenberg R, Siegert SI, Kammerer R, Nelson PJ, Noessner E. Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging. J Mol Med (Berl) 2012; 90:55 - 66; http://dx.doi.org/10.1007/s00109-011-0806-7; PMID: 21870102
   PubMed Web of Science ®Google Scholar
• Gati A, Da Rocha S, Guerra N, Escudier B, Moretta A, Chouaib S, Angevin E, Caignard A. Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients. Int J Cancer 2004; 109:393 - 401; http://dx.doi.org/10.1002/ijc.11730; PMID: 14961578
   PubMed Web of Science ®Google Scholar
• Schleypen JS, Von Geldern M, Weiss EH, Kotzias N, Rohrmann K, Schendel DJ, Falk CS, Pohla H. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Int J Cancer 2003; 106:905 - 12; http://dx.doi.org/10.1002/ijc.11321; PMID: 12918068
   PubMed Web of Science ®Google Scholar
• Perier A, Fregni G, Wittnebel S, Gad S, Allard M, Gervois N, Escudier B, Azzarone B, Caignard A. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Oncogene 2011; 30:2622 - 32; http://dx.doi.org/10.1038/onc.2010.638; PMID: 21258414
   PubMed Web of Science ®Google Scholar
• Wittnebel S, Da Rocha S, Giron-Michel J, Jalil A, Opolon P, Escudier B, Validire P, Khawam K, Chouaib S, Azzarone B, et al. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis. Cancer Res 2007; 67:5594 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-4406; PMID: 17575122
   PubMed Web of Science ®Google Scholar